TGFB3 and head and neck squamous cell carcinoma: HNSCC cell lines that exhibit resistance to the widely used chemotherapeutic cisplatin, released EVs carrying TGF-β3 and were capable of transferring the drug-resistant phenotype to sensitive cells through activation of TGF-β signaling (Rodrigues-Junior et al., 2019).